PLTP regulates STAT3 and NFκB in differentiated THP1 cells and human monocyte-derived macrophages

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1813, Issue 10, 2011, Pages 1917-1924

  Vuletic, S ^a   Dong, W ^a,b   Wolfbauer, G ^a   Tang, C ^a   Albers, J J ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b MEDICAL SCHOOL OF XI AN JIAOTONG UNIVERSITY   (China)

Author keywords

Differentiated THP1 cell; Human monocyte derived macrophage; Inflammation; NF B reduction; STAT3 activation

Indexed keywords

ABC TRANSPORTER A1; CYTOKINE; GAMMA INTERFERON; GLIBENCLAMIDE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; JANUS KINASE 2; PHOSPHOLIPID TRANSFER PROTEIN; SHORT HAIRPIN RNA; STAT3 PROTEIN; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR ALPHA;

ANTIGEN PRESENTING CELL; ARTICLE; CELL DIFFERENTIATION; CELL SURVIVAL; CELL VIABILITY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; ENZYME ACTIVATION; HUMAN; HUMAN CELL; IN VITRO STUDY; MACROPHAGE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; WILD TYPE;

ATP-BINDING CASSETTE TRANSPORTERS; BIOLOGICAL TRANSPORT; CELL DIFFERENTIATION; CELL LINE, TUMOR; CELL NUCLEUS; GLYBURIDE; HUMANS; HYPOGLYCEMIC AGENTS; INFLAMMATION; INTERFERON-GAMMA; LEUKEMIA; MACROPHAGES; NF-KAPPA B; PHOSPHOLIPID TRANSFER PROTEINS; PHOSPHOLIPIDS; STAT3 TRANSCRIPTION FACTOR; TUMOR NECROSIS FACTOR-ALPHA;

BACTERIA (MICROORGANISMS);

EID: 80051795660     PISSN: 01674889     EISSN: 18792596     Source Type: Journal    
DOI: 10.1016/j.bbamcr.2011.06.013     Document Type: Article

References (49)

1. Hailman E., Albers J.J., Wolfbauer G., Tu A.Y., Wright S.D. Neutralization and transfer of lipopolysaccharide by phospholipid transfer protein. J. Biol. Chem. 1996, 271:12172-12178.
2. Wolfbauer G., Albers J.J., Oram J.F. Phospholipid transfer protein enhances removal of cellular cholesterol and phospholipids by high-density lipoprotein apolipoproteins. Biochim. Biophys. Acta 1999, 1439:65-76.
3. Barlage S., Froehlich D., Bottcher A., Jauhiainen M., Mueller H.P., Noetzel F., Rothe G., Schutt C., Linke R.P., Lanker K.J., Ehnholm C., Schmitz G. ApoE-containing high density lipoproteins and phospholipid transfer protein activity increase in patients with systemic inflammatory response. J. Lipid Res. 2001, 42:281-290.
4. Desrumaux C., Risold P.Y., Schroeder H., Deckert V., Masson D., Athias A., Laplanche H., Le Guern N., Biache D., Jiang X.C., Tall A.R., Desor D., Lagrost L. Phospholipid transfer protein (PLTP) deficiency reduces brain vitamin E content and increases anxiety in mice. FASEB J. 2005, 19:296-297.
5. Klein A., Deckert V., Schneider M., Dutrillaux F., Hammann A., Athias A., Le Guern N., Pais de Barros J.P., Desrumaux C., Masson D., Jiang X.C., Lagrost L. Alpha-tocopherol modulates phosphatidylserine externalization in erythrocytes: relevance in phospholipid transfer protein-deficient mice. Arterioscler. Thromb. Vasc. Biol. 2006, 26:2160-2167.
6. Wehinger A., Tancevski I., Schgoer W., Eller P., Hochegger K., Morak M., Hermetter A., Ritsch A., Patsch J.R., Foeger B. Phospholipid transfer protein augments apoptosis in THP1-derived macrophages induced by lipolyzed hypertriglyceridemic plasma. Arterioscler. Thromb. Vasc. Biol. 2007, 27:908-915.
7. Scheideler M., Elabd C., Zaragosi L.E., Chiellini C., Hackl H., Sanchez-Cabo F., Yadav S., Duszka K., Friedl G., Papak C., Prokesch A., Windhager R., Ailhaud G., Dani C., Amri E.Z., Trojanoski Z. Comparative transcriptomics of human multipotent stem cells during adipogenesis and osteoblastogenesis. BMC Genomics 2008, 9:340.
8. Dong W., Albers J.J., Vuletic S. Phospholipid transfer protein (PLTP) reduces phosphorylation of tau in human neuronal cells. J. Neurosci. Res. 2009, 87:3176-3185.
9. O'Brien K.D., Vuletic S., McDonald T.O., Wolfbauer G., Lewis K., Tu A.Y., Marcovina S., Wight T.N., Chait A., Albers J.J. Cell-associated and extracellular phospholipid transfer protein in human coronary atherosclerosis. Circulation 2003, 108:270-274.
10. Cheung M.C., Brown B.G., Marino Larsen E.K., Frutkin A.D., O'Brien K.D., Albers J.J. Phospholipid transfer protein activity is associated with inflammatory markers in patients with cardiovascular disease. Biochim. Biophys. Acta 2006, 1762:131-137.
11. Yatsuya H., Tamakoshi K., Hattori H., Otsuka R., Wada K., Zhang H., Mabuchi T., Ishikawa M., Murata C., Yoshida T., Kondo T., Toyoshima H. Serum phospholipid transfer protein mass as a possible protective factor for coronary heart diseases. Circ. J. 2004, 68:11-16.
12. Attia N., Nakbi A., Smaoui M., Chaaba R., Moulin P., Hammami S., Hamda K.B., Chanussot F., Hammami M. Increased phospholipid transfer protein activity associated with the impaired cellular cholesterol efflux in type 2 diabetic subjects with coronary artery disease. Tohoku J. Exp. Med. 2007, 213:129-137.
13. Schgoer W., Mueller T., Jauhiainen M., Wehinger A., Gander R., Tancevski I., Salzmann K., Eller P., Ritsch A., Haltmayer M., Ehnholm C., Patsch J.R., Foeger B. Low phospholipid transfer protein (PLTP) is a risk factor for peripheral atherosclerosis. Atherosclerosis 2008, 196:219-226.
14. Masson D., Jiang X.C., Lagrost L., Tall A.R. The role of plasma lipid transfer proteins in lipoprotein metabolism and atherogenesis. J. Lipid Res. 2009, 50:S201-S206.
15. Vuletic S., Jin L.W., Marcovina S.M., Peskind E.R., Moller T., Albers J.J. Widespread distribution of PLTP in human CNS: evidence for PLTP synthesis by glia and neurons, and increased levels in Alzheimer's disease. J. Lipid Res. 2003, 44:1113-1123.
16. Vuletic S., Peskind E.R., Marcovina S.M., Quinn J.F., Cheung M.C., Kennedy H., Kaye J.A., Jin L.W., Albers J.J. Reduced CSF PLTP activity in Alzheimer's disease and other neurologic diseases: PLTP induces apoE secretion in primary human astrocytes in vitro. J. Neurosci. Res. 2005, 80:406-413.
17. Desrumaux C.M., Mak P.A., Boisvert W.A., Masson D., Stupack D., Jauiainen M., Ehnholm C., Curtiss L.K. Phospholipid transfer protein is present in human atherosclerotic lesions and expressed by macrophages and foam cells. J. Lipid Res. 2003, 44:1453-1461.
18. Laffitte B.A., Joseph S.B., Chen M., Castrillo A., Repa J., Wilpitz D., Mangelsdorf D., Tondonoz P. The phospholipid transfer protein gene is a liver X receptor target expressed by macrophages in atherosclerotic lesions. Mol. Cell. Biol. 2003, 23:2181-2191.
19. Valenta D.T., Ogier N., Bradshaw G., Black A.S., Bonnet D.J., Lagrost L., Curtiss L.K., Desrumaux C.M. Atheroprotective potential of macrophage-derived phospholipid transfer protein in low-density lipoprotein receptor-deficient mice is overcome by apolipoprotein AI overexpression. Arterioscler. Thromb. Vasc. Biol. 2006, 26:1572-1578.
20. Valenta D.T., Bulgrien J.J., Bonnet D.J., Curtiss L.K. Macrophage PLTP is atheroprotective in LDLr-deficient mice with systematic PLTP deficiency. J. Lipid Res. 2008, 49:24-32.
21. Oram J.F., Wolfbauer G., Vaughan A.M., Tang C., Albers J.J. Phospholipid transfer protein interacts with and stabilizes ATP-binding cassette transporter A1 and enhances cholesterol efflux from cells. J. Biol. Chem. 2003, 278:52379-52385.
22. Oram J.F., Wolfbauer G., Tang C., Davidson W.S., Albers J.J. An amphipathic helical region of the N-terminal barrel of phospholipid transfer protein is critical for ABCA1-dependent cholesterol efflux. J. Biol. Chem. 2008, 283:11541-11549.
23. Albers J.J., Wolfbauer G., Cheung M.C., Day J.R., Ching A.F., Lok S., Tu A.Y. Functional expression of human and mouse plasma phospholipid transfer protein: effect of recombinant and plasma PLTP on HDL subspecies. Biochim. Biophys. Acta 1995, 1258:27-34.
24. O'Doherty U., Swiggard W.J., Malim M.H. Human immunodeficiency virus type 1 spinoculation enhances infection through virus binding. J. Virol. 2000, 74:10074-10080.
25. Cheung M.C., Wolfbauer G., Albers J.J. Plasma phospholipid mass transfer rate: relationship to plasma phospholipid and cholesteryl ester transfer activities and lipid parameters. Biochim. Biophys. Acta 1996, 1303:103-110.
26. Vesy C.J., Kitchens R.L., Wolfbauer G., Albers J.J., Munford R.S. Lipopolysaccharide-binding protein and phospholipid transfer protein release lipopolysaccharides from Gram-negative bacterial membranes. Infect. Immun. 2000, 68:2410-2417.
27. Darnell J.E., Kerr I.M., Stark G.R. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 1994, 264:1415-1421.
28. Ihle J.N., Kerr I.M. Jaks and Stats in signaling by the cytokine receptor superfamily. Trends Genet. 1995, 11:69-74.
29. Ihle J.N. Cytokine receptor signalling. Nature 1995, 377:591-594.
30. von Eckardstein A., Langer C., Engel T., Schaukal I., Cignarella A., Reinhardt J., Lorkowksi S., Li Z., Zhou X., Cullen P., Assmann G. ATP binding cassette transporter ABCA1 modulates the secretion of apolipoprotein E from human monocyte-derived macrophages. FASEB J. 2001, 15:1555-1561.
31. Reddy S.T., Hama S., Ng C., Grijalva V., Navab M., Fogelman A.M. ATP-binding cassete transporter 1 participates in LDL oxidation by artery wall cells. Arterioscler. Thromb. Vasc. Biol. 2002, 22:1877-1883.
32. Flieger O., Engling A., Bucala R., Lue H., Nickel W., Bernhagen J. Regulated secretion of macrophage migration inhibitory factor is mediated by a non-classical pathway involving an ABC transporter. FEBS Lett. 2003, 551:78-86.
33. Wang N., Silver D.L., Thiele C., Tall A.R. ATP-binding cassette transporter A1 (ABCA1) functions as a cholesterol efflux regulatory protein. J. Biol. Chem. 2001, 276:23742-23747.
34. Williams L.M., Sarma U., Willets K., Smallie T., Brennan F., Foxwell B.M. Expression of constitutively active STAT3 can replicate the cytokine-suppression activity of interleukin-10 in human primary macrophages. J. Biol. Chem. 2007, 282:6965-6975.
35. Lawrence T. The nuclear factor NF-kappaB pathway in inflammation. Cold Spring Harb. Perspect. Biol. 2009, 1:a001651.
36. Cheung M.C., Vaisar T., Han X., Heinecke J.W., Albers J.J. Phospholipid transfer protein in human plasma associates with proteins linked to immunity and inflammation. Biochemistry 2010, 49:7314-7322.
37. Gautier T., Klein A., Deckert V., Desrumaux C., Ogier N., Sberna A.L., Paul C., La Guern N., Athias A., Montange T., Monier S., Piard F., Jiang X.C., Masson D., Lagrost L. Effects of plasma phospholipid transfer protein deficiency on lethal endotoxemia in mice. J. Biol. Chem. 2008, 283:18702-18710.
38. Levels J.L., Pajkrt D., Schultz M., Hoek F.J., van Tol A., Meijers J.C., van Deventer S.J. Alterations in lipoprotein homeostasis during human experimental endotoxemia and clinical sepsis. Biochim. Biophys. Acta 2007, 1771:1429-1438.
39. Vuletic S., Taylor B.A., Tofler G.H., Chait A., Marcovina S.M., Schenck K., Albers J.J. SAA and PLTP activity in plasma of periodontal patients before and after full-mouth tooth extraction. Oral Dis. 2008, 14:514-519.
40. Vikstedt R., Ye D., Metso J., Hildebrand R.B., van Berkel T.J., Ehnholm C., Jauhiainen M., van Eck M. Macrophage phospholipid transfer protein contributes significantly to total plasma phospholipid transfer activity and its deficiency leads to diminished atherosclerotic lesion development. Arterioscler. Thromb. Vasc. Biol. 2007, 27:578-586.
41. Lundberg A.M., Hansson G.K. Innate immune signals in atherosclerosis. Clin. Immunol. 2010, 134:5-24.
42. Hansson G.K. Inflammatory mechanisms in atherosclerosis. J. Thromb. Haemost. 2009, 7:328-331.
43. Hansson G.K., Robertson A.K., Söderberg-Nauclér C. Inflammation and atherosclerosis. Annu. Rev. Pathol. 2006, 1:297-329.
44. McNeill E., Channon K.M., Greaves D.R. Inflammatory cell recruitment in cardiovascular disease: murine models and potential clinical applications. Clin. Sci. (Lond.) 2010, 118:641-655.
45. Yin K., Liao D.F., Tang C.K. ATP-binding membrane cassette transporter A1 (ABCA1): a possible link between inflammation and reverse cholesterol transport. Mol. Med. 2010, 16:438-449.
46. Tang C., Liu Y., Kessler P.S., Vaughan A.M., Oram J.F. The macrophage cholesterol exporter ABCA1 functions as an anti-inflammatory receptor. J. Biol. Chem. 2009, 284:32336-32343.
47. Zhu X., Owen J.S., Wilson M.D., Li H., Griffiths G.L., Thomas M.J., Hilthold E.M., Fessler M.B., Parks J.S. Macrophage ABCA1 reduces MyD88-dependent Toll-like receptor trafficking to lipid rafts by reduction of lipid raft cholesterol. J. Lipid Res. 2010, 51:3196-3206.
48. Takeda K., Clausen B.E., Kaisho T., Tsujimura T., Terada N., Forster I., Akira S. Enhanced Th1 activity and development of chronic enterocolitis in mice devoid of Stat3 in macrophages and neutrophils. Immunity 1999, 10:39-49.
49. Matsukawa A., Takeda K., Kudo S., Maeda T., Kagayama M., Akira S. Aberrant inflammation and lethality to septic peritonitis in mice lacking STAT3 in macrophages and neutrophils. J. Immunol. 2003, 171:6198-6205.